Chelsea and Westminster Hospital has gone live with a mobile web application that will enable staff to respond even quicker to patients at risk of reaching critical conditions in hospital. The hospital has started rolling out 100 mobile devices to staff so they can use the ThinkVitals electronic observations tool to monitor patient vital signs. 
The WHO estimates the share of prescribed medication that is not taken or not taken correctly at 50%. In the EU alone an estimated 200,000 patients a year die earlier than necessary due to non-adherence. With a new strategic partnership, Berlin-Chemie Menarini and the German adherence specialist smartpatient are setting out to change this. 
Aridhia, the pioneering Scottish clinical and translational informatics company, has announced a partnership in the Netherlands which it says will unite two of Europe's leading providers of services to healthcare organisations, and expand Aridhia's service to the country. 
Merck, a leading company for innovative, top-quality high-tech products in healthcare, life science and performance materials, is calling for national and international start-ups to apply for funding of innovative ideas by August 14, 2015. The Accelerator program is aimed at young companies in the healthcare, life science, performance materials, and IT sectors. 
The clinical and business benefits of the use of open source software in the NHS have been laid out in full in a challenging white paper from healthcare software pioneer IMS MAXIMS. The firm's research director Paul Cooper has dispelled the myths surrounding open source software for the NHS and other healthcare providers by showing how its use can lead to greater clinical engagement, more flexible development, and greater value for money. 
Philips reports Q2 comparable sales growth of 3% to EUR 6 billion and operational results of EUR 501 million. Healthcare comparable sales grew 8% year-on-year. Excluding restructuring and acquisition-related charges and other items, EBITA margin increased by 20 basis points to 10.7% as strong operational improvements were largely offset by a significant negative currency impact.